Roger Faroux
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 48
- Colorectal Cancer Treatments and Studies 37
- Colorectal Cancer Surgical Treatments 11
- Pancreatic and Hepatic Oncology Research 6
- Cancer Immunotherapy and Biomarkers 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Julien Taı̈eb (15 shared papers)Michel Pierre Ducreux (5 shared papers)Gérard Lledo (5 shared papers)Thierry André (10 shared papers)Christophe Louvet (7 shared papers)Aimery de Gramont (4 shared papers)Céline Lepère (3 shared papers)Maria Giulia Zampino (1 shared paper)
In The Last Decade
Roger Faroux
83 papers receiving 6k citations
Roger Faroux's Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 3.9k
- Hepatology 265
- Cancer Research 309
- Pharmacology 211
- Geriatrics and Gerontology 67
Countries citing papers authored by Roger Faroux
This map shows the geographic impact of Roger Faroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Faroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Faroux more than expected).
Fields of papers citing papers by Roger Faroux
This network shows the impact of papers produced by Roger Faroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Faroux. The network helps show where Roger Faroux may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Faroux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Hit paper breakdown → | 2018 | 2184 |
| 2 | Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial Hit paper breakdown → | 2005 | 817 |
| 3 | Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study Hit paper breakdown → | 2019 | 410 |
| 4 | Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Hit paper breakdown → | 2022 | 225 |
| 5 | 2010 | 133 | |
| 6 | 2018 | 129 | |
| 7 | 2020 | 126 | |
| 8 | 2019 | 110 | |
| 9 | 2019 | 100 | |
| 10 | 2019 | 99 | |
| 11 | 2017 | 90 | |
| 12 | 2013 | 86 | |
| 13 | 2008 | 82 | |
| 14 | 2015 | 78 | |
| 15 | 2012 | 76 | |
| 16 | 1988 | 75 | |
| 17 | 2018 | 74 | |
| 18 | 2014 | 73 | |
| 19 | 2007 | 72 | |
| 20 | 2017 | 70 |
About Roger Faroux
Roger Faroux is a scholar working on Oncology, Hepatology, Gastroenterology, Pharmacology and Surgery, having authored 88 papers that have together received 6.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (37 papers), Colorectal Cancer Surgical Treatments (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Gastrointestinal Bleeding Diagnosis and Treatment (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (3.9k citations), Hepatology (265 citations), Cancer Research (309 citations), Pharmacology (211 citations) and Geriatrics and Gerontology (67 citations). Roger Faroux has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Julien Taı̈eb, Michel Pierre Ducreux, Gérard Lledo, Thierry André, Christophe Louvet, Aimery de Gramont, Céline Lepère, Maria Giulia Zampino, Alberto Zaniboni and Enrico Aitini. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Digestive and Liver Disease, Journal of Hepatology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.